APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enzalutamide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enzalutamide Tablets Market Analysis and Forecast 2026-2032

29 December 2025192 pages

Choose your research edition.

Industry ResearchEnzalutamide Tablets Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzalutamide Tablets Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Enzalutamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzalutamide Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzalutamide Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Enzalutamide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enzalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enzalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enzalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enzalutamide Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Enzalutamide Tablets include Astellas/Pfizer and AURISCO etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enzalutamide Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enzalutamide Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Enzalutamide Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enzalutamide Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enzalutamide Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enzalutamide Tablets sales, projected growth trends, production technology, application and end-user industry.

Enzalutamide Tablets Segment by Company

Astellas/Pfizer

AURISCO

Enzalutamide Tablets Segment by Type

40mg

80mg

Enzalutamide Tablets Segment by Application

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Castration- Resistant Prostate Cancer (NM-CRPC)

Enzalutamide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzalutamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzalutamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzalutamide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enzalutamide Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enzalutamide Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enzalutamide Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enzalutamide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 40mg Major Manufacturers Table 3. 80mg Major Manufacturers Table 4. Global Enzalutamide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Major Manufacturers Table 6. Castration- Resistant Prostate Cancer (NM-CRPC) Major Manufacturers Table 7. Enzalutamide Tablets Industry Trends Table 8. Enzalutamide Tablets Industry Drivers Table 9. Enzalutamide Tablets Industry Opportunities and Challenges Table 10. Enzalutamide Tablets Industry Restraints Table 11. Global Enzalutamide Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Enzalutamide Tablets Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Enzalutamide Tablets Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Enzalutamide Tablets Revenue Market Share by Region (2021-2026) Table 15. Global Enzalutamide Tablets Revenue Market Share by Region (2027-2032) Table 16. Global Enzalutamide Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Enzalutamide Tablets Sales by Region (2021-2026) & (K Units) Table 18. Global Enzalutamide Tablets Sales by Region (2027-2032) & (K Units) Table 19. Global Enzalutamide Tablets Sales Market Share by Region (2021-2026) Table 20. Global Enzalutamide Tablets Sales Market Share by Region (2027-2032) Table 21. Global Enzalutamide Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Enzalutamide Tablets Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Enzalutamide Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Enzalutamide Tablets Sales Market Share by Manufacturers (2021-2026) Table 25. Global Enzalutamide Tablets Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Enzalutamide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Enzalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Enzalutamide Tablets Manufacturers, Product Type & Application Table 29. Global Enzalutamide Tablets Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Enzalutamide Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Enzalutamide Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Enzalutamide Tablets Revenue Market Share by Type (2021-2026) Table 36. Global Enzalutamide Tablets Revenue Market Share by Type (2027-2032) Table 37. Global Enzalutamide Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 39. Global Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 40. Global Enzalutamide Tablets Sales Market Share by Type (2021-2026) Table 41. Global Enzalutamide Tablets Sales Market Share by Type (2027-2032) Table 42. Global Enzalutamide Tablets Price by Type (2021-2026) & (US$/Unit) Table 43. Global Enzalutamide Tablets Price by Type (2027-2032) & (US$/Unit) Table 44. Global Enzalutamide Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Enzalutamide Tablets Revenue Market Share by Application (2021-2026) Table 48. Global Enzalutamide Tablets Revenue Market Share by Application (2027-2032) Table 49. Global Enzalutamide Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 51. Global Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 52. Global Enzalutamide Tablets Sales Market Share by Application (2021-2026) Table 53. Global Enzalutamide Tablets Sales Market Share by Application (2027-2032) Table 54. Global Enzalutamide Tablets Price by Application (2021-2026) & (US$/Unit) Table 55. Global Enzalutamide Tablets Price by Application (2027-2032) & (US$/Unit) Table 56. Astellas/Pfizer Company Information Table 57. Astellas/Pfizer Business Overview Table 58. Astellas/Pfizer Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Astellas/Pfizer Enzalutamide Tablets Product Portfolio Table 60. Astellas/Pfizer Recent Development Table 61. AURISCO Company Information Table 62. AURISCO Business Overview Table 63. AURISCO Enzalutamide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. AURISCO Enzalutamide Tablets Product Portfolio Table 65. AURISCO Recent Development Table 66. North America Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 67. North America Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 68. North America Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 69. North America Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 70. North America Enzalutamide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 71. North America Enzalutamide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 72. North America Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 73. North America Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 74. North America Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 75. North America Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 76. North America Enzalutamide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 77. North America Enzalutamide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 78. North America Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. North America Enzalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 80. North America Enzalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 81. North America Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 82. North America Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 83. North America Enzalutamide Tablets Sales by Country (2027-2032) & (K Units) Table 84. North America Enzalutamide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 85. North America Enzalutamide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 86. United States Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 87. Canada Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 88. Mexico Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 89. Europe Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 90. Europe Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 91. Europe Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 92. Europe Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 93. Europe Enzalutamide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 94. Europe Enzalutamide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 95. Europe Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 98. Europe Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 99. Europe Enzalutamide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 100. Europe Enzalutamide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 101. Europe Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. Europe Enzalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. Europe Enzalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. Europe Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. Europe Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 106. Europe Enzalutamide Tablets Sales by Country (2027-2032) & (K Units) Table 107. Europe Enzalutamide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 108. Europe Enzalutamide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 109. Germany Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 110. France Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 111. U.K. Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 112. Italy Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 113. Russia Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 114. Spain Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 115. Netherlands Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 116. Switzerland Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 117. Sweden Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 118. Poland Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 119. China Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 120. China Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 121. China Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 122. China Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 123. China Enzalutamide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Enzalutamide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 126. China Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 127. China Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 128. China Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 129. China Enzalutamide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Enzalutamide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 134. Asia Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 135. Asia Enzalutamide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Enzalutamide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 140. Asia Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 141. Asia Enzalutamide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Enzalutamide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Enzalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Enzalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 148. Asia Enzalutamide Tablets Sales by Country (2027-2032) & (K Units) Table 149. Asia Enzalutamide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Enzalutamide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 152. South Korea Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 153. India Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 154. Australia Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 155. Taiwan Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Enzalutamide Tablets Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Enzalutamide Tablets Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Enzalutamide Tablets Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Enzalutamide Tablets Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Enzalutamide Tablets Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Enzalutamide Tablets Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Enzalutamide Tablets Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Enzalutamide Tablets Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Enzalutamide Tablets Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Enzalutamide Tablets Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Enzalutamide Tablets Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Enzalutamide Tablets Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Enzalutamide Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Enzalutamide Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Enzalutamide Tablets Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Enzalutamide Tablets Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Enzalutamide Tablets Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Enzalutamide Tablets Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 178. Argentina Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 179. Chile Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 180. Colombia Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 181. Peru Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 183. Israel Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 184. UAE Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 185. Turkey Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 186. Iran Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 187. Egypt Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Enzalutamide Tablets Distributors List Table 191. Enzalutamide Tablets Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Enzalutamide Tablets Image Figure 2. Global Enzalutamide Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzalutamide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 40mg Image Figure 5. 80mg Image Figure 6. Global Enzalutamide Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Enzalutamide Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 8. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Image Figure 9. Castration- Resistant Prostate Cancer (NM-CRPC) Image Figure 10. Global Enzalutamide Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Enzalutamide Tablets Revenue (2021-2032) & (US$ Million) Figure 12. Global Enzalutamide Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Enzalutamide Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Enzalutamide Tablets Revenue Market Share by Region (2021-2032) Figure 15. Global Enzalutamide Tablets Sales (2021-2032) & (K Units) Figure 16. Global Enzalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Enzalutamide Tablets Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Enzalutamide Tablets Sales YoY (2021-2032) & (K Units) Figure 19. Europe Enzalutamide Tablets Sales YoY (2021-2032) & (K Units) Figure 20. China Enzalutamide Tablets Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Enzalutamide Tablets Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Enzalutamide Tablets Sales YoY (2021-2032) & (K Units) Figure 23. Global Enzalutamide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Enzalutamide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Enzalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Enzalutamide Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Enzalutamide Tablets Revenue Market Share by Type (2021-2032) Figure 29. Global Enzalutamide Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Enzalutamide Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Enzalutamide Tablets Sales Market Share by Type (2021-2032) Figure 32. Global Enzalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Enzalutamide Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Enzalutamide Tablets Revenue Market Share by Application (2021-2032) Figure 35. Global Enzalutamide Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Enzalutamide Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Enzalutamide Tablets Sales Market Share by Application (2021-2032) Figure 38. North America Enzalutamide Tablets Revenue Share by Type (2021-2032) Figure 39. North America Enzalutamide Tablets Sales Share by Type (2021-2032) Figure 40. North America Enzalutamide Tablets Revenue Share by Application (2021-2032) Figure 41. North America Enzalutamide Tablets Sales Share by Application (2021-2032) Figure 42. North America Enzalutamide Tablets Revenue Share by Country (2021-2032) Figure 43. North America Enzalutamide Tablets Sales Share by Country (2021-2032) Figure 44. Europe Enzalutamide Tablets Revenue Share by Type (2021-2032) Figure 45. Europe Enzalutamide Tablets Sales Share by Type (2021-2032) Figure 46. Europe Enzalutamide Tablets Revenue Share by Application (2021-2032) Figure 47. Europe Enzalutamide Tablets Sales Share by Application (2021-2032) Figure 48. Europe Enzalutamide Tablets Revenue Share by Country (2021-2032) Figure 49. Europe Enzalutamide Tablets Sales Share by Country (2021-2032) Figure 50. China Enzalutamide Tablets Revenue Share by Type (2021-2032) Figure 51. China Enzalutamide Tablets Sales Share by Type (2021-2032) Figure 52. China Enzalutamide Tablets Revenue Share by Application (2021-2032) Figure 53. China Enzalutamide Tablets Sales Share by Application (2021-2032) Figure 54. Asia Enzalutamide Tablets Revenue Share by Type (2021-2032) Figure 55. Asia Enzalutamide Tablets Sales Share by Type (2021-2032) Figure 56. Asia Enzalutamide Tablets Revenue Share by Application (2021-2032) Figure 57. Asia Enzalutamide Tablets Sales Share by Application (2021-2032) Figure 58. Asia Enzalutamide Tablets Revenue Share by Country (2021-2032) Figure 59. Asia Enzalutamide Tablets Sales Share by Country (2021-2032) Figure 60. SAMEA Enzalutamide Tablets Revenue Share by Type (2021-2032) Figure 61. SAMEA Enzalutamide Tablets Sales Share by Type (2021-2032) Figure 62. SAMEA Enzalutamide Tablets Revenue Share by Application (2021-2032) Figure 63. SAMEA Enzalutamide Tablets Sales Share by Application (2021-2032) Figure 64. SAMEA Enzalutamide Tablets Revenue Share by Country (2021-2032) Figure 65. SAMEA Enzalutamide Tablets Sales Share by Country (2021-2032) Figure 66. Enzalutamide Tablets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Enzalutamide Tablets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 40mg
  • 80mg
Applications
  • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  • Castration- Resistant Prostate Cancer (NM-CRPC)
Companies covered
  • Astellas/Pfizer
  • AURISCO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enzalutamide Tablets Market by Type
  3. 1.2.1 Global Enzalutamide Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 40mg
  5. 1.2.3 80mg
  6. 1.3 Enzalutamide Tablets Market by Application
  7. 1.3.1 Global Enzalutamide Tablets Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
  9. 1.3.3 Castration- Resistant Prostate Cancer (NM-CRPC)
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Enzalutamide Tablets Market Dynamics
  1. 2.1 Enzalutamide Tablets Industry Trends
  2. 2.2 Enzalutamide Tablets Industry Drivers
  3. 2.3 Enzalutamide Tablets Industry Opportunities and Challenges
  4. 2.4 Enzalutamide Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enzalutamide Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enzalutamide Tablets Revenue by Region
  3. 3.2.1 Global Enzalutamide Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enzalutamide Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Enzalutamide Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Enzalutamide Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enzalutamide Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enzalutamide Tablets Sales by Region
  9. 3.4.1 Global Enzalutamide Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enzalutamide Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Enzalutamide Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Enzalutamide Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enzalutamide Tablets Revenue by Manufacturers
  2. 4.1.1 Global Enzalutamide Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enzalutamide Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enzalutamide Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enzalutamide Tablets Sales by Manufacturers
  6. 4.2.1 Global Enzalutamide Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enzalutamide Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enzalutamide Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enzalutamide Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enzalutamide Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enzalutamide Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enzalutamide Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Enzalutamide Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enzalutamide Tablets Market CR5 and HHI
  16. 4.8.2 2025 Enzalutamide Tablets Tier 1, Tier 2, and Tier 3
5 Enzalutamide Tablets Market by Type
  1. 5.1 Global Enzalutamide Tablets Revenue by Type
  2. 5.1.1 Global Enzalutamide Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enzalutamide Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enzalutamide Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enzalutamide Tablets Sales by Type
  6. 5.2.1 Global Enzalutamide Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enzalutamide Tablets Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Enzalutamide Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enzalutamide Tablets Price by Type
6 Enzalutamide Tablets Market by Application
  1. 6.1 Global Enzalutamide Tablets Revenue by Application
  2. 6.1.1 Global Enzalutamide Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enzalutamide Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enzalutamide Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enzalutamide Tablets Sales by Application
  6. 6.2.1 Global Enzalutamide Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enzalutamide Tablets Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Enzalutamide Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enzalutamide Tablets Price by Application
7 Company Profiles
  1. 7.1 Astellas/Pfizer
  2. 7.1.1 Astellas/Pfizer Company Information
  3. 7.1.2 Astellas/Pfizer Business Overview
  4. 7.1.3 Astellas/Pfizer Enzalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Astellas/Pfizer Enzalutamide Tablets Product Portfolio
  6. 7.1.5 Astellas/Pfizer Recent Developments
  7. 7.2 AURISCO
  8. 7.2.1 AURISCO Company Information
  9. 7.2.2 AURISCO Business Overview
  10. 7.2.3 AURISCO Enzalutamide Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AURISCO Enzalutamide Tablets Product Portfolio
  12. 7.2.5 AURISCO Recent Developments
8 North America
  1. 8.1 North America Enzalutamide Tablets Market Size by Type
  2. 8.1.1 North America Enzalutamide Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Enzalutamide Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Enzalutamide Tablets Price by Type (2021-2032)
  5. 8.2 North America Enzalutamide Tablets Market Size by Application
  6. 8.2.1 North America Enzalutamide Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Enzalutamide Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Enzalutamide Tablets Price by Application (2021-2032)
  9. 8.3 North America Enzalutamide Tablets Market Size by Country
  10. 8.3.1 North America Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enzalutamide Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Enzalutamide Tablets Market Size by Type
  2. 9.1.1 Europe Enzalutamide Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enzalutamide Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Enzalutamide Tablets Price by Type (2021-2032)
  5. 9.2 Europe Enzalutamide Tablets Market Size by Application
  6. 9.2.1 Europe Enzalutamide Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enzalutamide Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Enzalutamide Tablets Price by Application (2021-2032)
  9. 9.3 Europe Enzalutamide Tablets Market Size by Country
  10. 9.3.1 Europe Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enzalutamide Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Enzalutamide Tablets Market Size by Type
  2. 10.1.1 China Enzalutamide Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Enzalutamide Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Enzalutamide Tablets Price by Type (2021-2032)
  5. 10.2 China Enzalutamide Tablets Market Size by Application
  6. 10.2.1 China Enzalutamide Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Enzalutamide Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Enzalutamide Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enzalutamide Tablets Market Size by Type
  2. 11.1.1 Asia Enzalutamide Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enzalutamide Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Enzalutamide Tablets Price by Type (2021-2032)
  5. 11.2 Asia Enzalutamide Tablets Market Size by Application
  6. 11.2.1 Asia Enzalutamide Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enzalutamide Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Enzalutamide Tablets Price by Application (2021-2032)
  9. 11.3 Asia Enzalutamide Tablets Market Size by Country
  10. 11.3.1 Asia Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enzalutamide Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enzalutamide Tablets Market Size by Type
  2. 12.1.1 SAMEA Enzalutamide Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enzalutamide Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enzalutamide Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Enzalutamide Tablets Market Size by Application
  6. 12.2.1 SAMEA Enzalutamide Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enzalutamide Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enzalutamide Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Enzalutamide Tablets Market Size by Country
  10. 12.3.1 SAMEA Enzalutamide Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enzalutamide Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enzalutamide Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enzalutamide Tablets Value Chain Analysis
  2. 13.1.1 Enzalutamide Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enzalutamide Tablets Production Mode & Process
  6. 13.2 Enzalutamide Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enzalutamide Tablets Distributors
  9. 13.2.3 Enzalutamide Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst